These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16389386)

  • 1. Brachytherapy as a treatment option for prostate cancer: overview and nursing considerations.
    Brumm J
    Proc (Bayl Univ Med Cent); 2000 Jul; 13(3):227-9. PubMed ID: 16389386
    [No Abstract]   [Full Text] [Related]  

  • 2. Brachytherapy in the Management of Prostate Cancer.
    Stish BJ; Davis BJ; Mynderse LA; Deufel CL; Choo R
    Surg Oncol Clin N Am; 2017 Jul; 26(3):491-513. PubMed ID: 28576185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a high-dose-rate prostate brachytherapy program.
    Waring J; Gosselin T
    Clin J Oncol Nurs; 2010 Apr; 14(2):199-205. PubMed ID: 20350893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose brachytherapy for treating prostate cancer: nursing considerations.
    Colella J; Scrofine S
    Urol Nurs; 2004 Feb; 24(1):39-44, 52. PubMed ID: 15054909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose rate prostate brachytherapy.
    Stish BJ; Davis BJ; Mynderse LA; McLaren RH; Deufel CL; Choo R
    Transl Androl Urol; 2018 Jun; 7(3):341-356. PubMed ID: 30050795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial brachytherapy for prostate cancer--just an expensive variant of 'watchful waiting'?
    Walther PJ
    Curr Opin Urol; 1999 May; 9(3):201-4. PubMed ID: 10726090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical considerations in permanent brachytherapy for localized adenocarcinoma of the prostate.
    Stone NN; Stock RG
    Urol Clin North Am; 2003 May; 30(2):351-62. PubMed ID: 12735510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate brachytherapy. An overview.
    Porter AT; Forman JD
    Cancer; 1993 Feb; 71(3 Suppl):953-8. PubMed ID: 8428345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing considerations in brachytherapy-related erectile dysfunction.
    Stipetich R; Abel LJ; Anderson RL; Butler WM; Wallner KE; Merrick GS
    Urol Nurs; 2005 Aug; 25(4):249-54; quiz 259. PubMed ID: 16225341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?
    Wang JZ; Li XA; Yu CX; DiBiase SJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1101-8. PubMed ID: 14575842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer.
    Langley SE; Laing RW
    Prostate Cancer Prostatic Dis; 2004; 7(3):201-7. PubMed ID: 15184864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer.
    Crook J; Lukka H; Klotz L; Bestic N; Johnston M;
    CMAJ; 2001 Apr; 164(7):975-81. PubMed ID: 11314451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nursing management of patients receiving brachytherapy for early stage prostate cancer.
    Abel LJ; Blatt HJ; Stipetich RL; Fuscardo JA; Zeroski D; Miller SE; Dorsey AT; Butler WM; Merrick GS
    Clin J Oncol Nurs; 1999 Jan; 3(1):7-15. PubMed ID: 10232167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer.
    Maenhout M; Peters M; van Vulpen M; Moerland MA; Meijer RP; van den Bosch MAAJ; Nguyen PL; Frank SJ; van der Voort van Zyp JRN
    Technol Cancer Res Treat; 2017 Dec; 16(6):1194-1201. PubMed ID: 29333958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer high dose-rate brachytherapy: review of evidence and current perspectives.
    Dutta SW; Alonso CE; Libby B; Showalter TN
    Expert Rev Med Devices; 2018 Jan; 15(1):71-79. PubMed ID: 29251165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-year experience at Mount Sinai Medical Center.
    Marshall RA; Buckstein M; Stone NN; Stock R
    Urol Oncol; 2014 Jan; 32(1):38.e1-7. PubMed ID: 23769266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer.
    ; Frank SJ; Arterbery VE; Hsu IC; Abdel-Wahab M; Ciezki JP; Hahn NM; Mohler JL; Moran BJ; Rosenthal SA; Rossi CJ; Yamada Y; Merrick G
    Brachytherapy; 2011; 10(5):357-62. PubMed ID: 21497562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Feasibility of Low-Dose Rate Brachytherapy for Prostate Cancer in Renal Transplant Recipients.
    Iizuka J; Hashimoto Y; Hashimoto Y; Kondo T; Takagi T; Nozaki T; Shimizu T; Akimoto T; Ishida H; Karasawa K; Tanabe K
    Transplant Proc; 2016 Apr; 48(3):910-3. PubMed ID: 27234765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-fraction brachytherapy as monotherapy for early-stage prostate cancer: The UCSF experience.
    Xu MJ; Chen KS; Chang AJ; Lazar A; Shinohara K; Cunha JAM; Hsu IC
    Brachytherapy; 2019; 18(4):470-476. PubMed ID: 30954399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transperineal image-guided permanent brachytherapy for localized cancer of the prostate.
    Nag S; Fernandes PS; Bahnson R
    Urol Oncol; 1998; 4(6):191-202. PubMed ID: 21227258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.